Emeryville, CA, United States of America

Xiaohua Xin

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaohua Xin. Retrieved from https://idiyas.com/inventor/xiaohua-xin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 24.0

ph-index = 1

Forward Citations = 56(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Xiaohua Xin

Introduction: Xiaohua Xin is a pioneering inventor based in Emeryville, California, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Xiaohua Xin holds several patents in the areas of artificial intelligence, machine learning, and robotics, showcasing his commitment to pushing the boundaries of technological advancement.

Career Highlights: With a career spanning over two decades, Xiaohua Xin has worked with leading tech companies, research institutions, and universities, honing his expertise in developing cutting-edge solutions that have revolutionized the industry.

Collaborations: Xiaohua Xin has collaborated with top researchers, engineers, and scientists from around the world, fostering a culture of innovation and knowledge-sharing that has led to significant advancements in the field.

Conclusion: Xiaohua Xin's relentless pursuit of innovation and his passion for creating transformative technologies have solidified his reputation as a visionary inventor at the forefront of technological progress.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…